Canadian Cancer Trials Group Bulletins

Trial Management Group


Trials Closed to Accrual

Canadian Cancer Trials Group IND. 204 - A Phase II Study of PX-866 in Patients with Glioblastoma Multiforme at Time of First Relapse or Progression -- was closed to accrual on September 24, 2012, after achieving its protocol-mandated accrual target.